CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 47 filers reported holding CATALYST BIOSCIENCES INC in Q1 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $89,000 | +74.5% | 21,563 | +82.8% | 0.01% | +100.0% |
| Q2 2021 | $51,000 | -81.6% | 11,794 | -78.6% | 0.00% | -85.0% |
| Q1 2021 | $277,000 | +25.9% | 55,000 | +58.0% | 0.02% | +33.3% |
| Q4 2020 | $220,000 | +24.3% | 34,800 | -15.4% | 0.02% | +25.0% |
| Q3 2020 | $177,000 | +37.2% | 41,111 | +87.7% | 0.01% | +33.3% |
| Q2 2020 | $129,000 | +22.9% | 21,900 | -8.6% | 0.01% | +12.5% |
| Q1 2020 | $105,000 | +31.2% | 23,949 | +104.7% | 0.01% | +60.0% |
| Q4 2019 | $80,000 | -41.6% | 11,700 | -58.1% | 0.01% | -37.5% |
| Q3 2019 | $137,000 | -33.5% | 27,900 | 0.0% | 0.01% | -33.3% |
| Q2 2019 | $206,000 | – | 27,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,076,376 | $13,321,000 | 6.97% |
| 22NW, LP | 1,429,242 | $6,189,000 | 1.66% |
| Ghost Tree Capital, LLC | 1,000,000 | $4,330,000 | 1.19% |
| ACUTA CAPITAL PARTNERS, LLC | 685,000 | $2,966,000 | 1.18% |
| Sio Capital Management, LLC | 623,892 | $2,701,000 | 0.67% |
| Parkman Healthcare Partners LLC | 393,449 | $1,704,000 | 0.37% |
| Nantahala Capital Management | 2,531,360 | $10,961,000 | 0.31% |
| AlphaCentric Advisors LLC | 182,500 | $790,000 | 0.22% |
| Ikarian Capital, LLC | 581,200 | $2,518,000 | 0.20% |
| Tibra Equities Europe Ltd | 79,200 | $343,000 | 0.11% |